Triple Negative Breast Cancer: pDC vs. cDC | STUDY
The groundbreaking findings showed that high levels of pDC were significantly associated with improved survival in triple negative breast cancer (TNBC), whereas cDC did not show the same correlation.
Unraveling Dendritic Cells in Glioblastoma Immunotherapy
Glioblastoma (GBM), a devastating primary brain cancer, remains a formidable challenge with a median survival of less than 15 months despite current standard treatments of surgery, radiation, and chemotherapy.
STUDY: Dendritic Cell Vaccine Therapy for Colorectal Cancer
In the pursuit of disrupting tumor growth, a groundbreaking approach emerges through dendritic cell (DC) vaccines that target tumor-derived blood vessels, unleashing potent immune responses to combat cancer.
Traditional cancer treatments often fall short due to their lack of specificity, leading to therapy resistance and cancer recurrence. However, exciting breakthroughs in stem cell biology have opened up new
Regenerative abilities of mesenchymal stem cells through mitochondrial transfer
Over the past decade, researchers have uncovered the fascinating role of mitochondrial transfer by mesenchymal stem cells (MSCs) in regenerating damaged cells and tissues.
